Skip to Main Content

Paper Details

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.
Clin Pharmacol Ther
79
2014
AHA, G6PD, G6PD deficiency, G6PD genotype, G6PD genotypes, G6PD-deficient, Glucose, Glucose-, Glucose-6-phosphate dehydrogenase, Glucose-6-phosphate dehydrogenase (G6PD) deficiency, Rasburicase, acute hemolytic anemia, methemoglobinemia, patients, rasburicase
Author NameAffiliation
Mary V RellingDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital
Ellen M McDonaghStanford University
Howard L McLeodPersonalized Medicine Institute, Moffitt Cancer Center
Howard L McLeodPersonalized Medicine Institute, Moffitt Cancer Center
Cyrine E HaidarDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital
Teri E KleinStanford University
  • 1 - 6

Datasets

Release 1.2